Cue HealthNASDAQ: HLTH

SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. ("Cue" or the “Company”) (Nasdaq: HLTH), a healthcare technology company, today announced the Company has filed voluntary petitions under Chapter 7 of the U.S. Bankruptcy Code in the District of Delaware to pursue a wind down of its business. Cue has been working diligently to strengthen the Company's financial foundation, including taking a number of actions to reduce costs and improve operational efficiency. Cue also undertook an extensive process t.

Listen, if you haven't gotten the memo, penny stocks are incredibly dangerous. Yes, they're cheap – in this case, extremely cheap.

Cue Health Inc. (HLTH) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.45. This compares to loss of $0.50 per share a year ago.

Cue Health Inc. (NASDAQ:HLTH ) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Lorna Williams - Investor Relations Ayub Khattak - Chairman, President and Chief Executive Officer Aasim Javed - Chief Financial Officer Conference Call Participants Charles Rhyee - TD Cowen Operator Good day and thank you for standing by. Welcome to the Cue Health Third Quarter 2023 Earnings Conference Call.

Cue Health Inc. (NASDAQ:HLTH ) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants Lorna Williams - IR Ayub Khattak - Co-Founder, President, CEO & Chairman Aasim Javed - CFO Conference Call Participants David Delahunt - Goldman Sachs Charles Rhyee - TD Cowen Operator Good day and thank you for standing by. Welcome to the Cue Health Second Quarter 2023 Earnings Conference Call.

Cue Health Inc. (HLTH) came out with a quarterly loss of $0.51 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to loss of $0.37 per share a year ago.

The U.S. Food and Drug Administration on Tuesday approved Cue Health's at-home COVID-19 test, the first coronavirus test to get marketing authorization using a traditional premarket review, the agency said.

Cue Health Inc. (HLTH) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Cue Health Inc. (HLTH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).